Neuroinflammatory processes, particularly glial activation, dysregulation of PTEN-induced putative kinase 1 (Pink1) and Nrf2 pathways, and cytokine release, have been strongly associated with the development of anxiety and depression after ICH [24,73,76,80,81,83,86]. The gene discussed is PINK1; the disease is depressive symptom measurement.